Cargando…

1759. Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002–2016

BACKGROUND: Adults with immunocompromising conditions are at increased risk of herpes zoster (HZ) infection and related complications. We aimed to assess the incidence of HZ seen in hospital or emergency department in immunocompromised populations and compare it to that of immunocompetent population...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchan, Sarah, Wang, John, Wilson, Sarah, Wormsbecker, Anne E, Garber, Gary, Daneman, Nick, Deeks, Shelley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809384/
http://dx.doi.org/10.1093/ofid/ofz360.1622
_version_ 1783461974558900224
author Buchan, Sarah
Wang, John
Wilson, Sarah
Wormsbecker, Anne E
Garber, Gary
Daneman, Nick
Deeks, Shelley
author_facet Buchan, Sarah
Wang, John
Wilson, Sarah
Wormsbecker, Anne E
Garber, Gary
Daneman, Nick
Deeks, Shelley
author_sort Buchan, Sarah
collection PubMed
description BACKGROUND: Adults with immunocompromising conditions are at increased risk of herpes zoster (HZ) infection and related complications. We aimed to assess the incidence of HZ seen in hospital or emergency department in immunocompromised populations and compare it to that of immunocompetent populations. METHODS: Using healthcare administrative data, we calculated incidence rates (IR) of HZ in Ontario, Canada between April 1, 2002 and August 31, 2016 in adults ≥18 years categorized as immunocompromised or immunocompetent. We repeated these analyses by type of immunocompromising condition and provided incidence rate ratios (IRR) comparing to immunocompetent adults. We also calculated IRs and IRRs of HZ complications by immunocompromised status. RESULTS: There were 120,654 incident cases of HZ seen in hospital or emergency department during the study period. Immunocompromised adults accounted for 13% of these cases despite representing only 3% of the population. The risk of HZ was higher for immunocompromised adults compared with immunocompetent (IRR = 2.8, 95% CI 2.8–2.9) and ranged across type of immunocompromising condition (from 2.4 [95% CI 2.3–2.5] in those with a solid tumor malignancy to 11.0 [95% CI 10.0–12.0] in those who had undergone a hematopoietic stem cell transplant). The risk of any HZ complication was also higher in immunocompromised adults (IRR = 3.5, 95% CI 3.4–3.6) and was highest for disseminated zoster (IRR = 31.5, 95% CI 26.3–37.5). CONCLUSION: The risk of HZ and related complications was higher in immunocompromised populations compared with immunocompetent. Our findings underscore the high-risk nature of this population and the potential benefits that may be realized through HZ vaccination of this group. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6809384
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68093842019-10-28 1759. Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002–2016 Buchan, Sarah Wang, John Wilson, Sarah Wormsbecker, Anne E Garber, Gary Daneman, Nick Deeks, Shelley Open Forum Infect Dis Abstracts BACKGROUND: Adults with immunocompromising conditions are at increased risk of herpes zoster (HZ) infection and related complications. We aimed to assess the incidence of HZ seen in hospital or emergency department in immunocompromised populations and compare it to that of immunocompetent populations. METHODS: Using healthcare administrative data, we calculated incidence rates (IR) of HZ in Ontario, Canada between April 1, 2002 and August 31, 2016 in adults ≥18 years categorized as immunocompromised or immunocompetent. We repeated these analyses by type of immunocompromising condition and provided incidence rate ratios (IRR) comparing to immunocompetent adults. We also calculated IRs and IRRs of HZ complications by immunocompromised status. RESULTS: There were 120,654 incident cases of HZ seen in hospital or emergency department during the study period. Immunocompromised adults accounted for 13% of these cases despite representing only 3% of the population. The risk of HZ was higher for immunocompromised adults compared with immunocompetent (IRR = 2.8, 95% CI 2.8–2.9) and ranged across type of immunocompromising condition (from 2.4 [95% CI 2.3–2.5] in those with a solid tumor malignancy to 11.0 [95% CI 10.0–12.0] in those who had undergone a hematopoietic stem cell transplant). The risk of any HZ complication was also higher in immunocompromised adults (IRR = 3.5, 95% CI 3.4–3.6) and was highest for disseminated zoster (IRR = 31.5, 95% CI 26.3–37.5). CONCLUSION: The risk of HZ and related complications was higher in immunocompromised populations compared with immunocompetent. Our findings underscore the high-risk nature of this population and the potential benefits that may be realized through HZ vaccination of this group. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809384/ http://dx.doi.org/10.1093/ofid/ofz360.1622 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Buchan, Sarah
Wang, John
Wilson, Sarah
Wormsbecker, Anne E
Garber, Gary
Daneman, Nick
Deeks, Shelley
1759. Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002–2016
title 1759. Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002–2016
title_full 1759. Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002–2016
title_fullStr 1759. Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002–2016
title_full_unstemmed 1759. Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002–2016
title_short 1759. Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002–2016
title_sort 1759. incidence of hospitalizations and emergency department visits for herpes zoster in immunocompromised and immunocompetent adults in ontario, canada, 2002–2016
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809384/
http://dx.doi.org/10.1093/ofid/ofz360.1622
work_keys_str_mv AT buchansarah 1759incidenceofhospitalizationsandemergencydepartmentvisitsforherpeszosterinimmunocompromisedandimmunocompetentadultsinontariocanada20022016
AT wangjohn 1759incidenceofhospitalizationsandemergencydepartmentvisitsforherpeszosterinimmunocompromisedandimmunocompetentadultsinontariocanada20022016
AT wilsonsarah 1759incidenceofhospitalizationsandemergencydepartmentvisitsforherpeszosterinimmunocompromisedandimmunocompetentadultsinontariocanada20022016
AT wormsbeckerannee 1759incidenceofhospitalizationsandemergencydepartmentvisitsforherpeszosterinimmunocompromisedandimmunocompetentadultsinontariocanada20022016
AT garbergary 1759incidenceofhospitalizationsandemergencydepartmentvisitsforherpeszosterinimmunocompromisedandimmunocompetentadultsinontariocanada20022016
AT danemannick 1759incidenceofhospitalizationsandemergencydepartmentvisitsforherpeszosterinimmunocompromisedandimmunocompetentadultsinontariocanada20022016
AT deeksshelley 1759incidenceofhospitalizationsandemergencydepartmentvisitsforherpeszosterinimmunocompromisedandimmunocompetentadultsinontariocanada20022016